YOLFTbeta
Q/C Technologies, Inc.

Q/C Technologies, Inc.

QCLS · NASDAQ · Technology / Computer Hardware

0.3101USD+0.00 (+0.36%)

Price History

Full chart

Market Stats

Previous Close0.309
Open0.324
Day Range0.3063 – 0.3532
52-Week Range0.42 – 8.17
Volume136.03K
Market Cap7.11M
P/E (TTM)0.00
Forward P/E0.00
EPS177.81
Dividend Yield0.00%
Beta2.11
50-Day Avg2.31
200-Day Avg3.62

About

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. In addition, it is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications;. The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.

Company Details

  • SectorTechnology
  • IndustryComputer Hardware
  • CEOMr. Joshua N. Silverman
  • Employees3
  • Headquarters1185 Avenue of the Americas, New York, NY, United States, 10036, USA
  • Websitehttps://www.qctechnologies.com

Leadership

  • Mr. Joshua N. SilvermanExecutive Chairman of the Board · b. 1970
  • Mr. Ian Thomas Rhodes CPAChief Financial Officer · b. 1973
  • Dr. Mitchell Glass M.D.Chief Medical Officer & Director · b. 1952

Financials

Income Statement

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-00000
Cost of Revenue29.45K00000
Gross Profit-29.45K00000
Operating Expense9.46M28.81M15.28M17.12M10.17M9.85M
Operating Income-9.49M-28.81M-15.28M-17.12M-10.17M-9.85M
EBITDA-8.28M-29.28M-15.20M-16.36M-8.66M-11.63M
Net Income-9.49M-29.89M-15.20M-4.00M-23.36M-11.63M
R&D2.47M6.75M9.07M7.87M3.44M3.47M
Interest Expense-608.46K0---

Balance Sheet

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets676.70K24.81M17.54M17.86M21.42M41.17M
Total Liabilities5.93M1.17M2.84M5.09M6.70M19.41M
Total Equity-5.26M23.65M14.70M12.77M14.72M21.75M
Cash148.28K555.97K749.09K2.68M173.15K987.00K
Total Debt4.13M149.15K141.72K48.87K10.58K-
Net Debt3.98M-406.82K-607.37K-2.63M-162.57K-987.00K

Cash Flow

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-11.92M-19.52M-12.27M-12.98M-8.98M-9.07M
Investing Cash Flow-8.76M19.85M6.91M1.85M-6.10M-8.42M
Financing Cash Flow38.67M73.53K5.55M13.07M12.57M18.30M
Capital Expenditure000002.01M
Free Cash Flow-11.92M-19.52M-12.27M-12.98M-8.98M-11.07M
Dividends Paid--01.45M1.36M77.63K
FCF to OCF100.00%100.00%100.00%100.00%100.00%122.16%
Dividend Paid to FCF--0.00%-11.19%-15.11%-0.70%

Earnings

Report DateSep 30, 2013May 14, 2014Aug 12, 2014Nov 13, 2014Mar 23, 2015May 14, 2015Aug 18, 2015Nov 13, 2015Mar 30, 2016May 12, 2016Aug 11, 2016Nov 14, 2016Mar 29, 2017May 11, 2017Aug 15, 2017Nov 15, 2017Apr 3, 2018Aug 15, 2018Nov 15, 2018Mar 27, 2019May 20, 2019Aug 13, 2019Nov 14, 2019Feb 26, 2020May 13, 2020Aug 18, 2020Nov 12, 2020Mar 3, 2021May 17, 2021Aug 18, 2021Nov 18, 2021Mar 2, 2022May 16, 2022Aug 17, 2022Nov 10, 2022Mar 1, 2023May 22, 2023Aug 16, 2023Nov 16, 2023Feb 28, 2024May 20, 2024Aug 14, 2024Nov 25, 2024Feb 26, 2025May 15, 2025Aug 19, 2025Nov 19, 2025Dec 31, 2025Mar 31, 2026Aug 12, 2026Nov 18, 2026
EPS Estimate------------0.00--602.83-0.06----------------------------------
EPS Actual-423096.96-163444.97-120213.98-262996.98-212098.85-297066.19-467135.92-521023.96-794880.00-320418.79-214157.87691.20-55.68-0.19-921.60-1497.60-0.13-230.40-374.40-2.09-2.03-1.92-2.06-1.89-46.29-50.04-50.72-0.24-54.14-104.32-103.11-100.46-94.22-0.09-0.09-0.09-0.04-337.64192.55-293.53-513.84-454.50-110.99-93.23-0.36-17.66-2.50-0.85-0.19-0.79-
Surprise---------------52.88%--316.67%----------------------------------
Timing---------------------------------------------------

Key Statistics & Ratios

Market Cap7.11M
Enterprise Value-3.31M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book0.45
EPS177.81
Book Value1.95
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-108.00%
Return on Assets-33.44%
Shares Outstanding8.19M
Shares Float8.11M
Beta2.11
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
9.02%
Insiders
7.53%
Retail / Other
83.45%

Top Institutional Holders

  • Jane Street Group LLC
    126.19K1.54%
  • Quinn Opportunity Partners LLC
    123.02K1.50%
  • UBS Group AG
    77.99K0.95%
  • ADAR1 Capital Management LLC
    50.00K0.61%
  • Geode Capital Management, LLC
    47.39K0.58%
  • Vanguard Capital Management, LLC
    37.51K0.46%
  • HRT FINANCIAL LLC
    22.40K0.27%
  • Dimensional Fund Advisors, Inc.
    19.06K0.23%
  • Vanguard Fiduciary Trust Co
    15.55K0.19%
  • State Street Corp
    12.90K0.16%
  • Pin Oak Investment Advisors Inc
    3.50K0.04%
  • Sunbelt Securities
    1.75K0.02%
  • Tower Research Capital LLC
    1.59K0.02%
  • BNP Paribas Arbitrage, SA
    3000.00%

Top Fund Holders

  • Fidelity Extended Market Index
    41.10K0.50%
  • DFA US Small Cap I
    13.19K0.16%
  • Fidelity Series Total Market Index
    12.99K0.16%
  • Fidelity Total Market Index
    10.45K0.13%
  • Fidelity Nasdaq Composite Index
    5.67K0.07%
  • Dimensional US Small Cap ETF
    5.57K0.07%

Stock Splits

  • Sep 2, 20251:100
  • Feb 15, 20241:30
  • Apr 19, 20211:2
  • Nov 25, 20191:24
  • Nov 8, 20181:8